Stay updated on Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows an updated revision label Revision: v3.6.5, and the Plain Language Summary section has been removed along with the older Revision: v3.6.4.
    Difference
    0.0%
    Check dated 2026-08-11T18:55:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version metadata rather than its content.
    Difference
    0.0%
    Check dated 2026-07-21T12:52:26.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Revision: v3.6.3 is now shown, replacing v3.6.0, signaling a version update to the page's underlying system. This change updates metadata and does not alter the study details or core content.
    Difference
    0.0%
    Check dated 2026-06-30T02:36:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added recruitment status note and new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revised Intervention/Treatment section; removed the older 'Intervention / Treatment' heading and the 'Revision: v3.5.5' note.
    Difference
    0.2%
    Check dated 2026-06-15T23:54:57.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small update to the page template or system, with no apparent changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-09T02:11:34.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The Locations section was updated to replace Kharkivs’ka Oblast’ with Kharkiv Oblast and to add a new entry for Kharkiv, Kharkiv Oblast, Ukraine, 61070; the former Kharkivs’ka Oblast’ entry (and its city/ZIP) was removed.
    Difference
    0.0%
    Check dated 2026-06-01T23:07:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.